Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, New Jersey, USA.
Institute for Quantitative Biomedicine, Rutgers University, Piscataway, New Jersey, USA.
Proteins. 2022 May;90(5):1044-1053. doi: 10.1002/prot.26208. Epub 2021 Aug 23.
Since the identification of the SARS-CoV-2 virus as the causative agent of the current COVID-19 pandemic, considerable effort has been spent characterizing the interaction between the Spike protein receptor-binding domain (RBD) and the human angiotensin converting enzyme 2 (ACE2) receptor. This has provided a detailed picture of the end point structure of the RBD-ACE2 binding event, but what remains to be elucidated is the conformation and dynamics of the RBD prior to its interaction with ACE2. In this work, we utilize molecular dynamics simulations to probe the flexibility and conformational ensemble of the unbound state of the receptor-binding domain from SARS-CoV-2 and SARS-CoV. We have found that the unbound RBD has a localized region of dynamic flexibility in Loop 3 and that mutations identified during the COVID-19 pandemic in Loop 3 do not affect this flexibility. We use a loop-modeling protocol to generate and simulate novel conformations of the CoV2-RBD Loop 3 region that sample conformational space beyond the ACE2 bound crystal structure. This has allowed for the identification of interesting substates of the unbound RBD that are lower energy than the ACE2-bound conformation, and that block key residues along the ACE2 binding interface. These novel unbound substates may represent new targets for therapeutic design.
自鉴定 SARS-CoV-2 病毒为当前 COVID-19 大流行的病原体以来,人们花费了大量精力来描述刺突蛋白受体结合域(RBD)与人类血管紧张素转换酶 2(ACE2)受体之间的相互作用。这提供了 RBD-ACE2 结合事件终点结构的详细图片,但仍需要阐明的是 RBD 在与 ACE2 相互作用之前的构象和动态。在这项工作中,我们利用分子动力学模拟来探测 SARS-CoV-2 和 SARS-CoV 的未结合状态的受体结合域的柔韧性和构象整体。我们发现,未结合的 RBD 在环 3 中具有局部区域的动态灵活性,并且在 COVID-19 大流行期间在环 3 中鉴定的突变不会影响这种灵活性。我们使用环建模协议来生成和模拟 CoV2-RBD 环 3 区域的新构象,这些构象采样了超越 ACE2 结合晶体结构的构象空间。这使得能够识别出未结合的 RBD 的有趣亚状态,这些亚状态的能量低于 ACE2 结合构象,并且阻止 ACE2 结合界面上的关键残基。这些新的未结合亚状态可能代表治疗设计的新目标。